What have we learnt from previous phase II trials to help in the management of childhood brain tumours?

Author： Chastagner P. Bouffet E. Grill J. Kalifa C.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.16, 2001-11, pp. : 1981-1993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why phase II trials in cervical chemoprevention are negative: what have we learned?

By Follen M.

Cancer Causes and Control, Vol. 13, Iss. 9, 2002-11 ,pp. : 855-873

Springer Publishing Company

Access to resources Recommend Favorite

Oral cancer screening: what have we learnt and what is there still to achieve?

By Brocklehurst Paul R Baker Sarah R M Speight Paul

Future Oncology, Vol. 6, Iss. 2, 2010-02 ,pp. : 299-304

Future Medicine

Access to resources Recommend Favorite

Clinical Trials with Retrovirus Mediated Gene Therapy – what Have we Learned?

By Rainov Nikolai G. Ren Huan

Journal of Neuro-Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 227-236

Springer Publishing Company

Access to resources Recommend Favorite

Management of brain metastases from germ cell tumors: do we know what we are doing?

By Raj Sanjay Parkinson Christine Williams Michael Mazhar Danish

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite

Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 1, 2016-02 ,pp. : 67-97

Bentham Science Publishers

Access to resources Recommend Favorite